Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

48.72
BATS BZX Real-Time Price
As of 11:53am ET
 -0.75 / -1.53%
Today’s Change
48.01
Today|||52-Week Range
66.55
-25.78%
Year-to-Date
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alp...
Sep 27 / Zacks.com - Paid Partner Content
Teva: This Is No Generic Downtrend
Sep 23 / TheStreet.com - Paid Partner Content
Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says
Sep 26 / TheStreet.com - Paid Partner Content
Teva Reports Positive Phase III Tardive Dyskinesia Data
Sep 23 / Zacks.com - Paid Partner Content
Andrew Left Says Trump and Clinton Agree on Just One Thing
Sep 26 / TheStreet.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
Teva Presents Top-Line Data from Huntington Disease Study
Sep 20 / Zacks.com - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
Sep 24 / MotleyFool.com - Paid Partner Content
Intel and Teva Partner on Cloud-based Healthcare Solutions
Sep 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.47
Today’s open49.55
Day’s range48.48 - 49.86
Volume271,702
Average volume (3 months)5,508,568
Market cap$50.2B
Dividend yield2.79%
Data as of 11:53am ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-2.72%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.22%
P/E ratio32.5
Price/Sales2.89
Price/Book1.70

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+1.57+5.32%
OASMOasmia Pharmaceutica...+0.01+0.25%
Data as of 11:48am ET, 09/28/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Search for Jobs